STAT3 and chondrosarcoma: Herein, in ATO-treated chondrosarcoma cells, for the first time, we identified that miR-125b exhibited a tumor suppressor function, which attenuated the EMT and invasive capacities by targeting Stat3, which is activated to trigger the molecular events in the EMT of various human tumors [50–54].